InHealth Policy PodcastbyAtlas Point Podcasts·Jan 21Ross Marchand on the 340B Drug Program and the Hidden Costs to Patients and TaxpayersIn this episode of the Health Policy Podcast, Ross Marchand, executive director of the Taxpayers Protection Alliance, examines how the…
Marko Fields·Aug 3, 2023Empowering Communities of Color: The 340B Program and HIV SupportThe 340B Drug Pricing Program is a game-changer in bridging healthcare disparities faced by communities of color, particularly in the…
AIR 340B·Dec 1, 202230 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and…With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing program? Is it truly…
AIR 340B·Aug 3, 2022AIR340B to FTC: Outsized role of PBMs in safety-net program harms vulnerable patientsFor vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving…
AIR 340B·May 11, 2021Congress should act on overwhelming support for changes to vital drug discount programBy: Former Congressman Bob Dold, AIR340B Spokesperson
